GALANIN GMAP-LIKE AND NPY-LIKE IMMUNOREACTIVITIES IN LOCUS-COERULEUS AND NORADRENERGIC NERVE-TERMINALS IN THE HIPPOCAMPAL-FORMATION AND CORTEX WITH NOTES ON THE GALANIN-R1 AND GALANIN-R2 RECEPTORS/
Zqd. Xu et al., GALANIN GMAP-LIKE AND NPY-LIKE IMMUNOREACTIVITIES IN LOCUS-COERULEUS AND NORADRENERGIC NERVE-TERMINALS IN THE HIPPOCAMPAL-FORMATION AND CORTEX WITH NOTES ON THE GALANIN-R1 AND GALANIN-R2 RECEPTORS/, Journal of comparative neurology, 392(2), 1998, pp. 227-251
By using immunofluorescence methodology, extensive galanin (GAL) and G
AL message-associated peptide (GMAP)-positive terminal networks were o
bserved in the hippocampal formation. The majority of the GAL/GMAP fib
ers were dopamine beta-hydroxylase-(DBH) positive, that is, they were
noradrenergic. This finding was established with GAL/GMAP-DBH double-s
taining and with 6-hydroxy-dopamine treatment, which totally abolished
all fibers in which GAL/GMAP and DBH coexisted. Also, reserpine treat
ment caused a marked depletion of GAL. No evidence for GAL/GMAP coexis
tence with 5-hydroxytryptamine was obtained. In the ventral hippocampu
s, GAL/GMAP-, DBH-negative fibers were seen in the stratum oriens, the
anterior stratum radiatum, along the granule cell layer and in the st
rata oriens and alveus. In the locus coeruleus (LC), around 80% of the
GMAP-positive neurons contained neuropeptide tyrosine (NPY), and abou
t 40% of the NPY-positive neurons expressed GMAP. GAL-Ri receptor mRNA
was expressed in Barrington's nucleus (close to the LC), but was not
detected in the hippocampal formation/dorsal cortical areas. GAL-RE re
ceptor mRNA was found in the granule cell layer in the dentate gyrus.
The present results show that most, but not all, immunohistochemically
detectable GAL/GMAP in the hippocampal formation/dorsal cortex is pre
sent in noradrenergic nerve terminals originating in the LC, which has
a robust GAL/GMAP synthesis. The functional role of GAL may be relate
d to noradrenaline, possibly by a presynaptic action. However, the pre
sence of GAL in other systems and of GAL-RE receptor mRNA in granule c
ells also indicates other targets. (C) 1998 Wiley-Liss, Inc.